TruScreen rises as high as 60% in compliance listing on NZAX

TruScreen rises as high as 60% in compliance listing on NZAX
By Suze Metherell Nov. 12 (BusinessDesk) - Shares of TruScreen, which develops a cervical cancer screening system, rose as much as 60 percent from the recent issue price of 10 cents in its compliance listing on the small-cap NZX Alternative Market. The stock debuted at 16 cents, and recently traded at 14 cents as $100,721 worth of shares changed hands, to give the company a market value of about $20 million, after the Auckland-based company listed 144.4 million ordinary shares on the NZAX. As a compliance listing, TruScreen didn't issue a...